Bio-Rad Laboratories EPS - Earnings per Share 2012-2025 | BIO
Bio-Rad Laboratories annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Bio-Rad Laboratories EPS for the quarter ending December 31, 2025 was $26.65, a 202.94% decline year-over-year.
- Bio-Rad Laboratories EPS for the twelve months ending December 31, 2025 was $27.91, a 142.7% decline year-over-year.
- Bio-Rad Laboratories 2025 annual EPS was $27.85, a 142.61% decline from 2024.
- Bio-Rad Laboratories 2024 annual EPS was $-65.36, a 199.54% increase from 2023.
- Bio-Rad Laboratories 2023 annual EPS was $-21.82, a 82.08% decline from 2022.
| Bio-Rad Laboratories Annual EPS | |
|---|---|
| 2025 | $27.85 |
| 2024 | $-65.36 |
| 2023 | $-21.82 |
| 2022 | $-121.79 |
| 2021 | $140.83 |
| 2020 | $126.47 |
| 2019 | $58.27 |
| 2018 | $12.10 |
| 2017 | $4.07 |
| 2016 | $0.88 |
| 2015 | $3.71 |
| 2014 | $3.05 |
| 2013 | $2.69 |
| 2012 | $5.78 |
| 2011 | $6.29 |
| Bio-Rad Laboratories Quarterly EPS | |
|---|---|
| 2025-12-31 | $26.65 |
| 2025-09-30 | $-12.70 |
| 2025-06-30 | $11.67 |
| 2025-03-31 | $2.29 |
| 2024-12-31 | $-25.89 |
| 2024-09-30 | $23.34 |
| 2024-06-30 | $-76.26 |
| 2024-03-31 | $13.45 |
| 2023-12-31 | $11.81 |
| 2023-09-30 | $3.64 |
| 2023-06-30 | $-39.59 |
| 2023-03-31 | $2.32 |
| 2022-12-31 | $27.24 |
| 2022-09-30 | $-5.48 |
| 2022-06-30 | $-31.05 |
| 2022-03-31 | $-112.50 |
| 2021-12-31 | $-51.83 |
| 2021-09-30 | $129.96 |
| 2021-06-30 | $30.32 |
| 2021-03-31 | $32.38 |
| 2020-12-31 | $27.96 |
| 2020-09-30 | $43.64 |
| 2020-06-30 | $32.15 |
| 2020-03-31 | $22.72 |
| 2019-12-31 | $18.35 |
| 2019-09-30 | $-8.68 |
| 2019-06-30 | $19.86 |
| 2019-03-31 | $28.74 |
| 2018-12-31 | $-27.43 |
| 2018-09-30 | $8.89 |
| 2018-06-30 | $8.87 |
| 2018-03-31 | $21.77 |
| 2017-12-31 | $2.76 |
| 2017-09-30 | $0.73 |
| 2017-06-30 | $0.17 |
| 2017-03-31 | $0.41 |
| 2016-12-31 | $-0.77 |
| 2016-09-30 | $0.62 |
| 2016-06-30 | $0.61 |
| 2016-03-31 | $0.42 |
| 2015-12-31 | $1.54 |
| 2015-09-30 | $0.59 |
| 2015-06-30 | $0.97 |
| 2015-03-31 | $0.61 |
| 2014-12-31 | $1.34 |
| 2014-09-30 | $0.39 |
| 2014-06-30 | $1.09 |
| 2014-03-31 | $0.23 |
| 2013-12-31 | $1.04 |
| 2013-09-30 | $-0.25 |
| 2013-06-30 | $1.20 |
| 2013-03-31 | $0.70 |
| 2012-12-31 | $1.51 |
| 2012-09-30 | $1.49 |
| 2012-06-30 | $1.69 |
| 2012-03-31 | $1.09 |
| 2011-12-31 | $2.11 |
| 2011-09-30 | $1.61 |
| 2011-06-30 | $1.41 |
| 2011-03-31 | $1.16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.921B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |